U.S. IT Stock News

NYSE:R
NYSE:RTransportation

A Look At Ryder System (R) Valuation After Analyst Optimism And Earnings Upside In A Soft Freight Market

Ryder System (R) is back on investors’ radar after a mix of upbeat analyst commentary, positive earnings surprises, and ongoing capital returns, including steady dividends and buybacks, despite a freight market that remains under pressure. See our latest analysis for Ryder System. The recent optimism around Ryder System has coincided with strong momentum, with a 30 day share price return of 13.3% and a 90 day share price return of 33.7%. The 1 year total shareholder return of 80.4% sits...
NYSE:COR
NYSE:CORHealthcare

What Cencora (COR)'s Expanded Role in Kite CAR T Distribution Means For Shareholders

Cencora recently announced an agreement with Kite, a Gilead Company, to support U.S. distribution of FDA-approved CAR T-cell therapies Yescarta and Tecartus, using its specialty infrastructure to ease access for an expanding network of authorized treatment centers. This move deepens Cencora’s presence in complex cell and gene therapies, highlighting its role in handling highly specialized, patient-specific treatments that can be operationally challenging for providers. Next, we’ll examine...
NYSE:SLG
NYSE:SLGOffice REITs

Is SL Green Realty (SLG) Fairly Priced After Its Recent Share Price Rebound

Recent performance snapshot and context SL Green Realty (SLG) has been drawing attention after a recent stretch of mixed returns, with the stock up over the past week and past 3 months but down over the past year. See our latest analysis for SL Green Realty. For context, the stock’s recent upswing, including a 27.02% 90 day share price return, contrasts with a 20.35% decline in 1 year total shareholder return. As a result, near term momentum appears to be rebuilding from a weaker longer term...
NYSE:GBCI
NYSE:GBCIBanks

Glacier Bancorp (GBCI) Valuation Check After Recent Mixed Share Price Performance

Glacier Bancorp (GBCI) stock has drawn fresh attention after recent trading left it around $47.12, with mixed short term returns that include gains over the past 3 months but a decline over the past month. See our latest analysis for Glacier Bancorp. At around $47.12, the stock’s recent 3 month share price return of 5.39% contrasts with a 3.42% move down over the past month, while the 1 year total shareholder return of 12.90% sits alongside a modest total shareholder loss over 5 years. This...
NYSE:RGA
NYSE:RGAInsurance

A Look At Reinsurance Group of America (RGA) Valuation As Shares Tread Water After Recent Moves

Recent performance and what has caught investors’ attention Reinsurance Group of America (RGA) has drawn fresh interest after recent share price moves, with the stock ending the latest session at US$201.21 and sitting slightly down year to date. Short term returns have been mixed, with the stock down about 2% over the past week, down roughly 4% over the past month, and lower by around 3% over the past 3 months, while the 1 year total return is slightly positive. See our latest analysis for...
NYSE:NOC
NYSE:NOCAerospace & Defense

If SpaceX’s Trillion Valuation Hits, These Space Giants Suffer

The SpaceX IPO hype is not just about one company; it is reshaping attention and capital around space and AI, and that can create both openings and pressure points for other stocks. With a US$75 billion offer for 5% of the company and a US$1.75 trillion valuation tied closely to its xAI ambitions, investors are suddenly rethinking which companies might lose out as money and headlines gravitate toward this new listing. This article highlights 3 stocks exposed to that news, each at risk of...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Extends Cystic Fibrosis Reach With Pediatric ALYFTREK And TRIKAFTA Data

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported new clinical data for its next-generation cystic fibrosis therapy ALYFTREK in young children. The company also outlined progress on global regulatory submissions for ALYFTREK and TRIKAFTA in pediatric populations. The updates focus on expanding treatment access to children as young as 2 years old and on long term safety findings in older patients. Vertex Pharmaceuticals sits at the center of the cystic fibrosis treatment market, and the latest...
NYSE:NGL
NYSE:NGLOil and Gas

Why NGL Energy Partners (NGL) Is Down 7.0% After Swinging to Loss but Keeping Buybacks Running

NGL Energy Partners LP has reported past fourth-quarter 2026 revenue of US$949.51 million and a net loss of US$287.68 million, reversing from profit a year earlier and contributing to a full-year loss on lower annual revenue of US$3.16 billion. Despite this swing into loss, the partnership continued its unit repurchase program through March 2026, retiring about 6.71% of outstanding units for roughly US$49.56 million, which may influence how investors interpret management’s confidence and...
NasdaqGS:DNUT
NasdaqGS:DNUTHospitality

Exploring Undervalued Small Caps With Insider Activity In June 2026

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with projected annual earnings growth of 17%. In this fluctuating environment, identifying small-cap stocks that are undervalued and exhibit insider activity can present unique opportunities for investors seeking to capitalize on potential market inefficiencies.
NYSE:NIC
NYSE:NICBanks

June 2026's Top Stocks Estimated To Be Below Fair Value

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this context, identifying stocks that are estimated to be below their fair value can present opportunities for investors looking to capitalize on potential growth amid current market fluctuations.
NasdaqCM:IMMX
NasdaqCM:IMMXBiotechs

Exploring 3 High Growth Tech Stocks in the US Market

Over the last 7 days, the United States market has dropped 2.7%, yet it remains up by 23% over the past year, with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that exhibit strong innovation potential and robust financial health to capitalize on future opportunities.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

3 Growth Stocks With High Insider Ownership And 29% Revenue Growth

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.
NasdaqGS:SGHT
NasdaqGS:SGHTMedical Equipment

Discover 3 Promising Penny Stocks With Market Caps Over $20M

Over the last 7 days, the U.S. market has dropped by 2.7%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. For investors interested in smaller or newer companies, penny stocks — despite being an older term — remain relevant as they can offer surprising value and growth potential when backed by strong financials. This article highlights several penny stocks that stand out for their financial strength, presenting opportunities for those seeking...
NasdaqGS:LKFN
NasdaqGS:LKFNBanks

3 Reliable Dividend Stocks Offering At Least 3.4% Yield

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this dynamic environment, reliable dividend stocks offering yields of at least 3.4% can provide a stable income stream while potentially benefiting from overall market growth.
NasdaqGM:CD
NasdaqGM:CDCapital Markets

If OpenAI’s IPO Reshapes Markets These IPO Stocks Could Jump

OpenAI’s confidential plan to go public at a potential valuation above $1t is not just a headline; it is a possible reset moment for how markets think about fast growing AI platforms and the companies around them. If investor appetite for this IPO is strong, it could influence pricing, expectations and capital flows across newer listings. This article highlights 3 stocks from our IPO Investment Opportunities screener that are exposed to this news in different ways, helping you decide whether...